Regional Deposition in Generic Dry Powder Inhalers
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm investigate regional deposition and simulated inhaled pharmacokinetic profiles of generic dry powder inhalers.
Alternative regulatory path for generic Respiratory Products
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/Brochure-956x667-4.png)
Explore Nanopharm’s SmartTrack, an alternative solution for FDA approval of generic inhalation drug delivery products.
Challenges in OINDPs Achieving Q3 Equivalence
![](https://nanopharm.co.uk/wp-content/uploads/2023/09/AptarPharmaScientificPublications_Icon.jpg)
Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.